Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
10/08/1998 | WO1998044104A2 Flip gene and flip protein |
10/08/1998 | WO1998043990A1 Gallic acid ester derivatives and drugs containing the same as the active ingredient |
10/08/1998 | WO1998043975A1 Pyrolopyrrolone derivatives |
10/08/1998 | WO1998043974A1 Pyrimidopyrimidine compounds |
10/08/1998 | WO1998043971A1 Novel pyridine derivatives and pharmaceutical compositions containing them |
10/08/1998 | WO1998043966A1 Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors |
10/08/1998 | WO1998043963A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
10/08/1998 | WO1998043960A1 Substituted 3-cyano quinolines |
10/08/1998 | WO1998043959A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
10/08/1998 | WO1998043954A1 Leukotriene a4 hydrolaze inhibitors |
10/08/1998 | WO1998043942A1 Novel compounds, their use and preparation |
10/08/1998 | WO1998043679A1 Human embryonic germ cell line and methods of use |
10/08/1998 | WO1998043666A1 Antioxidant protein 2, gene and methods of use therefor |
10/08/1998 | WO1998043662A1 Substances in order to achieve preference and create acceptance |
10/08/1998 | WO1998043648A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
10/08/1998 | WO1998043645A1 Inhibitors for the formation of glycosylated protein denaturation products |
10/08/1998 | WO1998043640A1 Benzocycloheptathiophene compounds |
10/08/1998 | WO1998043636A1 Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates |
10/08/1998 | WO1998043622A1 Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis |
10/08/1998 | WO1998043621A1 Nitrosylation to inactivate apoptotic enzymes |
10/08/1998 | WO1998043618A2 Use of cytoskeletal inhibitors for the prevention of restenosis |
10/08/1998 | WO1998043612A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma |
10/08/1998 | WO1998043554A1 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device |
10/08/1998 | WO1998043493A1 Pet food composition |
10/08/1998 | WO1998030558A3 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
10/08/1998 | WO1998028268A3 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS |
10/08/1998 | WO1998018429A3 A method for lowering plasma levels of lipoprotein(a) |
10/08/1998 | DE19722317C1 New human ryanodin receptor type 3 polypeptide |
10/08/1998 | DE19718012C1 Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe Process for the preparation perorally administered solid dosage forms with controlled drug delivery |
10/08/1998 | DE19713393A1 Flip-Gen und Flip-Protein Flip gene and flip-protein |
10/08/1998 | CA2286367A1 Pyrolopyrrolone derivatives |
10/08/1998 | CA2285669A1 Flip gene and flip protein |
10/08/1998 | CA2285631A1 Antioxidant protein 2, gene and methods of use therefor |
10/08/1998 | CA2285625A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis |
10/08/1998 | CA2285567A1 Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors |
10/08/1998 | CA2285434A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
10/08/1998 | CA2285372A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
10/08/1998 | CA2285274A1 Human embryonic germ cell line and methods of use |
10/08/1998 | CA2285241A1 Substituted 3-cyano quinolines |
10/08/1998 | CA2284940A1 Use of sodium channel blocker in the manufacture of a medicament for preventing optic nerve degeneration associated with glaucoma |
10/08/1998 | CA2284811A1 Pyrimidopyrimidine compounds |
10/08/1998 | CA2284597A1 Novel pyridine derivatives and pharmaceutical compositions containing them |
10/08/1998 | CA2283799A1 Novel human serine carboxypeptidase |
10/08/1998 | CA2283097A1 Use of inhibitors of undecaprenol kinase to inhibit cell wall biosynthesis |
10/07/1998 | EP0869180A1 A TNF homologue, TL5 |
10/07/1998 | EP0869179A1 Tumor necrosis related receptor, TR7 |
10/07/1998 | EP0869132A1 "Steroid compounds having contraceptive and anti-osteoporosis activity" |
10/07/1998 | EP0869122A1 Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof |
10/07/1998 | EP0869119A1 Phenoxymethyl piperidine derivatives being sodium channle blockers |
10/07/1998 | EP0868899A1 Use of a 2,3-dihydroxypropyl (1-oxo-alkyl) amin-2 deoxy-2glucopyranoside for the treatment of hairloss |
10/07/1998 | EP0868513A1 TGF$g(b) SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
10/07/1998 | EP0868430A1 Therapeutic compositions |
10/07/1998 | EP0868429A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
10/07/1998 | EP0868428A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
10/07/1998 | EP0868420A1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity |
10/07/1998 | EP0868194A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation |
10/07/1998 | EP0868180A1 Endothelin receptor antagonists |
10/07/1998 | EP0724566B1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
10/07/1998 | EP0720598B1 Phenoxyphenyl cyclopentenyl hydroxyureas |
10/07/1998 | EP0700282B1 Inhibition of hair growth |
10/07/1998 | EP0662948B1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
10/07/1998 | CN1195375A Angiostatin fragments and aggregate angiostatin and methods of use |
10/07/1998 | CN1195353A New inhibitors of platelet aggregation |
10/07/1998 | CN1195344A Polycyclic alcaloid-derivatives as NMDA-receptor antagonists |
10/07/1998 | CN1195340A Inhibitors of farnesyl-protein transferase |
10/07/1998 | CN1195295A Method and use of connective tissue growth factor as revellent |
10/07/1998 | CN1194983A New 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them |
10/07/1998 | CN1194978A Benzyloxy-substituted, fused N heterocycles, process for their preparation and their use as bradykinin receptor antagonists |
10/07/1998 | CN1194977A Phenoxymethyl piperidine derivatives |
10/07/1998 | CN1194848A Haemorrhoidolysis powder |
10/07/1998 | CN1040108C Process for preparing compound of benzyl indoles |
10/07/1998 | CN1040106C Process for preparing piperazine derivatives |
10/07/1998 | CN1040062C Process for preparing pharmacologically active catechol derivatives |
10/06/1998 | US5817836 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
10/06/1998 | US5817833 Antiserotonin agents; nervous system disorders; psychological disorders; antidepressants |
10/06/1998 | US5817800 Inhibitors of β-glucuronidase and their use in the treatment of carcinamatosis and inflammation |
10/06/1998 | US5817789 Bind to cell surface receptors; genetic engineering |
10/06/1998 | US5817742 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
10/06/1998 | US5817698 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists |
10/06/1998 | US5817683 Naphthoic derivative; hypotensive agent |
10/06/1998 | US5817674 Antiotensin ii receptor antagonists |
10/06/1998 | US5817671 Antiserotonin agent; analgesics; migraine therapy; compound containing pyrrolo(3,2-b)pyridine ring |
10/06/1998 | US5817649 Administering reductase inhibitor and an androgen receptor antagonist |
10/06/1998 | US5817648 Vitamin D3 analogues having an unsaturated side chain |
10/06/1998 | US5817643 Immunostimulants |
10/06/1998 | US5817631 Therapeutic uses of melanin |
10/06/1998 | US5817617 Selectin and pertussis toxin derived peptides and uses thereof |
10/06/1998 | US5817494 Anticancer agents; viricides |
10/06/1998 | US5817486 Recombinant human interleukin-3 (IL-3) multiple mutation polypeptides |
10/06/1998 | US5817485 Nucleic acids and cells for recombinant production of fibroblast growth factor-10 |
10/06/1998 | CA2167715C Heteroaryl cycloalkenyl hydroxyureas |
10/06/1998 | CA1340071C Dectection of infectious and inflammatory lesions using anti-leukocyte conjugates |
10/04/1998 | CA2232608A1 Use of 2,3-dihydroxypropyl (1-oxoalkyl)-2-amino-2-deoxy glucopyranosides for the treatment of hair loss |
10/03/1998 | CA2232147A1 Phenoxymethyl piperidine derivatives |
10/02/1998 | CA2233785A1 Tumor necrosis related receptor, tr7 |
10/02/1998 | CA2232743A1 A tnf homologue, tl5 |
10/01/1998 | WO1998043094A1 METHODS TO IDENTIFY β-AMYLOID REDUCING AGENTS |
10/01/1998 | WO1998042840A1 Motilin homologs |
10/01/1998 | WO1998042834A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
10/01/1998 | WO1998042747A1 Polypeptide with appetite regulating activity |